Back to Results
First PageMeta Content
Biology / Hepatitis / Health / Boceprevir / Cytokines / Hepatitis C / Hepatitis C and HIV co-infection / Interferon / Hepatocellular carcinoma / Protease inhibitors / Medicine / Antivirals


Microsoft PowerPoint - QC_Boceprevir_CORE_Strung.ppt
Add to Reading List

Open Document

File Size: 346,13 KB

Share Result on Facebook

Company

Merck Research Laboratories / SPRINT / EPO / /

Country

United States / /

Event

FDA Phase / /

Facility

Biostatistics University of North Carolina / /

IndustryTerm

active site / HCV therapy / HCV Therapies / Hepatitis C Therapies / food / /

MedicalCondition

CHC / HIV / HCV genotype 1 / hepatocellular carcinoma / HCV-RNA 24 / cirrhosis / compensated liver disease / hepatitis C / HCV / liver cirrhosis / infection / /

Organization

UCLA / School of Medicine / Chapel Hill / Johns Hopkins University School of Medicine / University of North Carolina / Medicine St Louis University School / Boceprevir FDA Antiviral Drugs Advisory Committee / /

Person

David Geffen / Safety Keith Gottesdiener / Janice K. Albrecht / Hill Fred Poordad / Keith Gottesdiener / Efficacy Clifford Brass / /

Position

Professor of Medicine David Geffen / Professor / Associate Professor of Medicine David / Professor of Medicine / /

Product

ribavirin / peginterferon / RESPOND-1 / /

ProvinceOrState

North Carolina / /

Technology

alpha / transplantation / genotype / /

SocialTag